{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:41:39Z","timestamp":1790757699204,"version":"4.1.0"},"reference-count":34,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ONF"],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1188\/17.onf.580-588","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T09:21:53Z","timestamp":1503048113000},"page":"580-588","source":"Crossref","is-referenced-by-count":38,"title":["The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure"],"prefix":"10.1188","volume":"44","author":[{"given":"Ellen","family":"Lavoie Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rylie","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kanzawa-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knoerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusara","family":"Prasertsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Donohoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alberti, P., Rossi, E., Cornblath, D.R., Merkies, I.S., Postma, T.J., Frigeni, B., . . . Cavaletti, G. (2014). Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin. Annals of Oncology, 25, 257\u2013264. doi:10.1093\/annonc\/mdt409","DOI":"10.1093\/annonc\/mdt409"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Argyriou, A.A., Kyritsis, A.P., Makatsoris, T., & Kalofonos, H.P. (2014). Chemotherapy-induced peripheral neuropathy in adults: A comprehensive update of the literature. Cancer Management and Research, 6, 135\u2013147. doi:10.2147\/CMAR.S44261","DOI":"10.2147\/CMAR.S44261"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Barton, D.L., Wos, E.J., Qin, R., Mattar, B.I., Green, N.B., Lanier, K.S., . . . Loprinzi, C.L. (2011). A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive Care in Cancer, 19, 833\u2013841. doi:10.1007\/s00520-010-0911-0","DOI":"10.1007\/s00520-010-0911-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Binner, M., Ross, D., & Browner, I. (2011). Chemotherapy-induced peripheral neuropathy: Assessment of oncology nurses\u2019 knowledge and practice. Oncology Nursing Forum, 38, 448\u2013454. doi:10.1188\/11.ONF.448-454","DOI":"10.1188\/11.ONF.448-454"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bridges, C.M., & Smith, E.M. (2014). What about Alice? Peripheral neuropathy from taxane-containing treatment for advanced nonsmall cell lung cancer. Supportive Care in Cancer, 22, 2581\u20132592. doi:10.1007\/s00520-014-2317-x","DOI":"10.1007\/s00520-014-2317-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Calhoun, E.A., Welshman, E.E., Chang, C.H., Lurain, J.R., Fishman, D.A., Hunt, T.L., & Cella, D. (2003). Psychometric evaluation of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-Neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecological Cancer, 13, 741\u2013748. doi:10.1111\/j.1525-1438.2003.13603.x ;","DOI":"10.1111\/j.1525-1438.2003.13603.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cavaletti, G., Cornblath, D.R., Merkies, I.S., Postma, T.J., Rossi, E., Frigeni, B., . . . Valsecchi, M.G. (2013). The Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization Study: From consensus to the first validity and reliability findings. Annals of Oncology, 24, 454\u2013462. doi:10.1093\/annonc\/mds329","DOI":"10.1093\/annonc\/mds329"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., . . . Bidoli, P. (2010). Chemotherapy-induced peripheral neurotoxicity assessment: A critical revision of the currently available tools. European Journal of Cancer, 46, 479\u2013494. doi:10.1016\/j.ejca.2009.12.008","DOI":"10.1016\/j.ejca.2009.12.008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Desaulniers, G.A. (2011). Chemotherapy induced peripheral neuropathy and subjective sleep quality in non-small cell lung cancer [Abstract 153]. Oncology Nursing Forum, 38, A56. doi:10.1188\/11.ONF.E60","DOI":"10.1188\/11.ONF.E60"},{"key":"10","unstructured":"DeVellis, R.F. (2003). Scale development: Theory and applications (2nd ed.). Thousand Oaks, CA: Sage."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Drennan, J. (2003). Cognitive interviewing: Verbal data in the design and pretesting of questionnaires. Journal of Advanced Nursing, 42, 57\u201363. doi:10.1046\/j.1365-2648.2003.02579.x ;","DOI":"10.1046\/j.1365-2648.2003.02579.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"England, J.D., Gronseth, G.S., Franklin, G., Miller, R.G., Asbury, A.K., Carter, G.T., . . . Sumner, A.J. (2005). Distal symmetric polyneuropathy: A definition for clinical research: Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology, 64, 199\u2013207. doi:10.1212\/01.WNL.0000149522.32823.EA","DOI":"10.1212\/01.WNL.0000149522.32823.EA"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Geber, C., Breimhorst, M., Burbach, B., Egenolf, C., Baier, B., Fechir, M., . . . Birklein, F. (2013). Pain in chemotherapy-induced neuropathy\u2014More than neuropathic? Pain, 154, 2877\u20132887. doi:10.1016\/j.pain.2013.08.028","DOI":"10.1016\/j.pain.2013.08.028"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Griffith, K.A., Merkies, I.S., Hill, E.E., & Cornblath, D.R. (2010). Measures of chemotherapy-induced peripheral neuropathy: A systematic review of psychometric properties. Journal of the Peripheral Nervous System, 15, 314\u2013325. doi:10.1111\/j.1529-8027.2010.00292.x","DOI":"10.1111\/j.1529-8027.2010.00292.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hibbard, J.H., & Greene, J. (2013). What the evidence shows about patient activation: Better health outcomes and care experiences; fewer data on costs. Health Affairs, 32, 207\u2013214.","DOI":"10.1377\/hlthaff.2012.1061"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kautio, A.-L., Haanp\u00e4\u00e4, M., Kautiainen, H., Kalso, E., & Saarto, T. (2011). Burden of chemotherapy-induced neuropathy\u2014A cross-sectional study. Supportive Care in Cancer, 19, 1991\u20131996. doi:10.1007\/s00520-010-1043-2","DOI":"10.1007\/s00520-010-1043-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Lavoie Smith, E.M., Barton, D.L., Qin, R., Steen, P.D., Aaronson, N.K., & Loprinzi, C.L. (2013). Assessing patient-reported peripheral neuropathy: The reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Quality of Life Research, 22, 2787\u20132799. doi:10.1007\/s11136-013-0379-8","DOI":"10.1007\/s11136-013-0379-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Loprinzi, C.L., Qin, R., Dakhil, S.R., Fehrenbacher, L., Flynn, K.A., Atherton, P., . . . Grothey, A. (2014). Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB\/Alliance). Journal of Clinical Oncology, 32, 997\u20131005. doi:10.1200\/JCO.2013.52.0536","DOI":"10.1200\/JCO.2013.52.0536"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Loprinzi, C.L., Reeves, B.N., Dakhil, S.R., Sloan, J.A., Wolf, S.L., Burger, K.N., . . . Lachance, D.H. (2011). Natural history of paclitaxel-associated acute pain syndrome: Prospective cohort study NCCTG N08C1. Journal of Clinical Oncology, 29, 1472\u20131478. doi:10.1200\/JCO.2010.33.0308","DOI":"10.1200\/JCO.2010.33.0308"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lynn, M.R. (1986). Determination and quantification of content validity. Nursing Research, 35, 382\u2013385.","DOI":"10.1097\/00006199-198611000-00017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Mols, F., Beijers, T., Lemmens, V., van den Hurk, C.J., Vreugdenhil, G., & van de Poll-Franse, L.V. (2013). Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: Results from the population-based PROFILES registry. Journal of Clinical Oncology, 31, 2699\u20132707. doi:10.1200\/JCO.2013.49.1514","DOI":"10.1200\/JCO.2013.49.1514"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Postma, T.J., Aaronson, N.K., Heimans, J.J., Muller, M.J., Hildebrand, J.G., Delattre, J.Y., . . . Lucey, R. (2005). The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer, 41, 1135\u20131139. doi:10.1016\/j.ejca.2005.02.012","DOI":"10.1016\/j.ejca.2005.02.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Reeves, B.N., Dakhil, S.R., Sloan, J.A., Wolf, S.L., Burger, K.N., Kamal, A., . . . Loprinzi, C.L. (2012). Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer, 118, 5171\u20135178. doi:10.1002\/cncr.27489","DOI":"10.1002\/cncr.27489"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Seretny, M., Currie, G.L., Sena, E.S., Ramnarine, S., Grant, R., MacLeod, M.R., . . . Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155, 2461\u20132470. doi:10.1016\/j.pain.2014.09.020","DOI":"10.1016\/j.pain.2014.09.020"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Smith, E.M., Campbell, G., Tofthagen, C., Kottschade, L., Collins, M.L., Warton, C., . . . Visovsky, C. (2014). Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy. Oncology Nursing Forum, 41, 669\u2013679. doi:10.1188\/14.ONF.669-679","DOI":"10.1188\/14.ONF.669-679"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Smith, E.M., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E.D., Ahles, T., . . . Shapiro, C.L. (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial. JAMA, 309, 1359\u20131367. doi:10.1001\/jama.2013.2813","DOI":"10.1001\/jama.2013.2813"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Tofthagen, C. (2010). Patient perceptions associated with chemotherapy-induced peripheral neuropathy [Online exclusive]. Clinical Journal of Oncology Nursing, 14, E22\u2013E28. doi:10.1188\/10.CJON.E22-E28","DOI":"10.1188\/10.CJON.E22-E28"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Tofthagen, C., Donovan, K.A., Morgan, M.A., Shibata, D., & Yeh, Y. (2013). Oxaliplatin-induced peripheral neuropathy\u2019s effects on health-related quality of life of colorectal cancer survivors. Supportive Care in Cancer, 21, 3307\u20133313. doi:10.1007\/s00520-013-1905-5","DOI":"10.1007\/s00520-013-1905-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Tofthagen, C., Overcash, J., & Kip, K. (2012). Falls in persons with chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer, 20, 583\u2013589. doi:10.1007\/s00520-011-1127-7","DOI":"10.1007\/s00520-011-1127-7"},{"key":"30","unstructured":"Tourangeau, R. (1984). Cognitive sciences and survey methods. In T.B. Jabine, M.L. Straf, J.M. Tanur, & R. Tourangeau (Eds.), Cognitive aspects of survey design: Building a bridge between disciplines (pp. 73\u2013100). Washington, DC: National Academies Press."},{"key":"31","doi-asserted-by":"crossref","unstructured":"Visovsky, C., Haas, M., Faiman, B., Kurtin, S., Schaftic, A.M., Lyden, E., & Rice, J. (2012). Nurse self-evaluation of assessment of chemotherapy-induced peripheral neuropathy in patients with cancer. Journal of the Advanced Practitioner in Oncology, 3, 319\u2013325.","DOI":"10.6004\/jadpro.2012.3.5.5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Visovsky, C., Meyer, R.R., Roller, J., & Poppas, M. (2008). Evaluation and management of peripheral neuropathy in diabetic patients with cancer. Clinical Journal of Oncology Nursing, 12, 243\u2013247. doi:10.1188\/08.CJON.243-247","DOI":"10.1188\/08.CJON.243-247"},{"key":"33","unstructured":"Waltz, C.F., Strickland, O.L., & Lenz, E.R. (Eds.). (2005). Measurement in nursing and health research (3rd ed.). New York, NY: Springer."},{"key":"34","unstructured":"Willis, G.B. (1999). Cognitive interviewing: A \u201chow to\u201d guide. Research Triangle Park, NC: Research Triangle Institute."}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/onf.ons.org\/onf\/44\/5\/content-validity-chemotherapy-induced-peripheral-neuropathy-patient-reported-outcome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:53Z","timestamp":1763754713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/44\/5\/content-validity-chemotherapy-induced-peripheral-neuropathy-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1188\/17.onf.580-588","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}